Positron Corporation (POSC)
OTCMKTS · Delayed Price · Currency is USD
1.650
0.00 (0.00%)
Oct 29, 2025, 1:08 PM EDT
Positron Revenue
Positron had revenue of $304.00K in the quarter ending September 30, 2015, a decrease of -23.23%. This brings the company's revenue in the last twelve months to $1.24M, down -26.50% year-over-year. In the year 2014, Positron had annual revenue of $1.47M, down -10.06%.
Revenue (ttm)
1.24M
Revenue Growth
-26.50%
P/S Ratio
41.46
Revenue / Employee
65.11K
Employees
19
Market Cap
51.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2014 | 1.47M | -164.00K | -10.06% |
| Dec 31, 2013 | 1.63M | -1.17M | -41.81% |
| Dec 31, 2012 | 2.80M | -3.86M | -57.96% |
| Dec 31, 2011 | 6.66M | 2.04M | 44.13% |
| Dec 31, 2010 | 4.62M | 3.18M | 219.71% |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Positron News
- 27 days ago - Positron Corporation Enters Industry Partnership Agreement with MedAxiom - GlobeNewsWire
- 4 weeks ago - Positron Corporation Wins Innovation Award in PET-CT Category from Medical Device Network's Excellence Awards 2025 - GlobeNewsWire
- 2 months ago - Positron Corporation Announces New Corporate Headquarters and Strategic Redomiciling to Delaware - GlobeNewsWire
- 2 months ago - Positron Corporation Secures Multi-Unit Sale of PET-CT Scanners to Leading Cardiology Group - GlobeNewsWire
- 5 months ago - Positron Corporation Expands Market Presence with Sale of NeuSight PET-CT Scanner - GlobeNewsWire
- 7 months ago - Positron Corporation Secures Agreement to Sell Four PET-CT Scanners - GlobeNewsWire
- 7 months ago - Positron Corporation Secures $8 Million in Capital to Accelerate Growth and Market Expansion - GlobeNewsWire
- 8 months ago - Positron Corporation Secures Agreement for Three NeuSight PET-CT 64 Slice Scanners - GlobeNewsWire